Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704
- William F. Regine
- , Kathryn Winter
- , Ross A. Abrams
- , Howard Safran
- , Ivan L. Kessel
- , Yuhchyau Chen
- , James A. Fugazzi
- , Eric D. Donnelly
- , Thomas A. DiPetrillo
- , Samir Narayan
- , John P. Plastaras
- , Rakesh Gaur
- , Guila Delouya
- , John H. Suh
- , Joshua E. Meyer
- , Michael G. Haddock
- , Mukund S. Didolkar
- , Gilbert D.A. Padula
- , David Johnson
- , John P. Hoffman
- University of Maryland
- NRG Oncology Statistics and Data Management Center
- Rush University
- Rhode Island Hospital
- University of Texas Medical Branch at Galveston
- University of Rochester
- Toledo Community Hospital Oncology Program
- Northwestern University
- Michigan Cancer Research Consortium
- University of Pennsylvania
- Kansas City CCOP
- Centre Hospitalier de l’Université de Montréal Research Center
- Cleveland Clinic Foundation
- Mayo Clinic
- Sinai Hospital of Baltimore
- Grand Rapids Clinical Oncology Program
- St. Francis Regional Medical Center
- Fox Chase Cancer Center
- University of Texas MD Anderson Cancer Center
- Memorial Sloan-Kettering Cancer Center
Research output: Contribution to journal › Article › peer-review
10
Scopus
citations